4,377.00
+54(+1.25%)
Currency In JPY
Address
408, Tashiro Daikan-machi
Tosu, 841-0017
Japan
Phone
81 3 5293 1720
Website
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2759
First IPO Date
January 01, 2001
| Name | Title | Pay | Year Born |
| Kazuhide Nakatomi | President, Chief Executive Officer & Representative Director | 0 | 1972 |
| Hidenao Minami | Executive Officer of Public Relations | 0 | N/A |
| Masaya Okuno | Senior Executive Officer and GM of the Pharmaceuticals & Cosmetics Division | 0 | N/A |
| Mitsutoshi Tsuruta | Senior Executive Officer & GM of Pharmaceutical Business Division | 0 | N/A |
| Koji Takiyama | Executive Officer, GM of President's Office, Digital Transformation, R&D, & HR Officer and Director | 0 | 1971 |
| Kyu Saito | MD, Executive Officer & Director | 0 | 1963 |
| Naruhito Higo | Managing Executive Officer, Head of Global Technology & Head of MN Business Promotion Office | 0 | N/A |
| Nobuo Tsutsumi | Exe Officer of Legal Affairs, Prod Environment, Reliability Assurance & Compliance and Director | 0 | 1964 |
| Shinichi Murayama | Executive Officer of Mgmt. of Internal Audit Division & Domestic Subsidiary Division and Director | 0 | 1967 |
| Tetsuo Akiyama | Senior Managing Executive Officer, Head of Business Operations & Head of BU | 0 | N/A |
Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. The company provides external pain relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; and BUTENALOCK, a remedy for athlete's foot, as well as ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, transdermal analgesic anti-inflammatory drug; patches for female hormone, asthma treatment, and treatment for overactive bladders. In addition, the company manufactures and sells drugs under MOHRUS TAPE, MOHRUS PAP XR, FENTOS Tapes, NEOXY Tapes, Abstral, ALLESAGA Tapes, HARUROPI Tapes, and MENOAID Combipatch. Further, it provides HFT-290, a transdermal patch for cancer pain. The company sells its products in the United States and Asia. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.